Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H6O3 |
| Molecular Weight | 126.11 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(O)C(=O)C=CO1
InChI
InChIKey=XPCTZQVDEJYUGT-UHFFFAOYSA-N
InChI=1S/C6H6O3/c1-4-6(8)5(7)2-3-9-4/h2-3,8H,1H3
| Molecular Formula | C6H6O3 |
| Molecular Weight | 126.11 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Maltol is a naturally occurring organic compound isolated from pine needles, larch bark, the destructive distillates of various organic materials and the alkaline hydrolysis products of streptomycin. Because of caramel-butterscotch odor, and suggestive of fruity-strawberry aroma in dilute solutions, maltol is used as a food additive mainly in confectionary and bakery products. Maltol is considered safe by FDA according to existing data and granted GRAS status. Maltol chelates metal ions such as Fe3+, Al3+, and is reported to increase uptake of aluminum and iron in the body. Maltol was reported to have a neuroprotective effect on retinal ganglion cells under oxidative stress, and hepatoprotective effect on alcohol-induced liver oxidative injury.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25646062 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| A Maillard reaction product enhances eNOS activity in human endothelial cells. | 2010-07 |
|
| Vanadate complexes in serum: a speciation modeling study. | 2010-01-07 |
|
| Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro. | 2009-11-16 |
|
| Identification of dihydromaltol (2,3-dihydro-5-hydroxy-6-methyl-4H-pyran-4-one) in Ryazhenka Kefir and comparative sensory impact assessment of related cycloenolones. | 2009-11-11 |
|
| Mixed-ligand copper(II) maltolate complexes: synthesis, characterization, DNA binding and cleavage, and cytotoxicity. | 2009-10-05 |
|
| Iron-binding characterization and polysaccharide production by Klebsiella oxytoca strain isolated from mine acid drainage. | 2009-10 |
|
| Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives. | 2009-05 |
|
| Biospeciation of various antidiabetic V(IV)O compounds in serum. | 2009-04-07 |
|
| Vanadium treatment of type 2 diabetes: a view to the future. | 2009-04 |
|
| Speciation in aqueous vanadate-ligand and peroxovanadate-ligand systems. | 2009-04 |
|
| Antidiabetic Bis-Maltolato-OxoVanadium(IV): conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B. | 2009-02-06 |
|
| Evaluation of the peroxynitrite scavenging activity of heat-processed ginseng. | 2009-02 |
|
| Synthesis of 4-pyridone-3-sulfate and an improved synthesis of 3-hydroxy-4-pyridone. | 2009-01-09 |
|
| Volatile compounds and sensorial characterization of wines from four Spanish denominations of origin, aged in Spanish Rebollo (Quercus pyrenaica Willd.) oak wood barrels. | 2008-10-08 |
|
| Aqueous Ln(III) luminescence agents derived from a tasty precursor. | 2008-09-15 |
|
| Effect of grain type and toasting conditions of barrels on the concentration of the volatile substances released by the wood and on the sensory characteristics of Montepulciano d'Abruzzo. | 2008-09 |
|
| Family meetings in palliative care: Multidisciplinary clinical practice guidelines. | 2008-08-19 |
|
| Singlet oxygen scavenging activity and cytotoxicity of essential oils from rutaceae. | 2008-07 |
|
| Interactions of insulin-mimetic zinc(II) complexes with cell constituents: glutathione and ATP. | 2008-07 |
|
| Determination of volatile organic compounds generated from fresh, white and red Panax ginseng (C. A. Meyer) using a direct sample injection technique. | 2008-05 |
|
| Unexpected C-H activation of Ru(II)-dithiomaltol complexes upon oxidation. | 2008-04-07 |
|
| Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies. | 2008-04 |
|
| The influence of citrate, maltolate and fluoride on the gastrointestinal absorption of aluminum at a drinking water-relevant concentration: A 26Al and 14C study. | 2008-04 |
|
| Speciation in the aqueous peroxovanadate-maltol and (peroxo)vanadate-uridine systems. | 2008-02-28 |
|
| Two new maltol glycosides and cyanogenic glycosides from Elsholtzia rugulosa Hemsl. | 2008-01 |
|
| Lanthanide containing compounds for therapeutic care in bone resorption disorders. | 2007-11-21 |
|
| Rapid sample screening method for authenticity controlling vanilla flavors using a CE microchip approach with electrochemical detection. | 2007-11 |
|
| A novel compound, maltolyl p-coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models. | 2007-08-15 |
|
| Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. | 2007-08-08 |
|
| Induction of cytochrome P450 1a1 by the food flavoring agent, maltol. | 2007-06 |
|
| Flavonol tetraglycosides and other constituents from leaves of Styphnolobium japonicum (Leguminosae) and related taxa. | 2007-05 |
|
| The identification of antioxidants in dark soy sauce. | 2007-04 |
|
| Study on the hydroxyl radical scavenging activity changes of ginseng and ginsenoside-Rb2 by heat processing. | 2007-04 |
|
| Subthreshold olfactory stimulation can enhance sweetness. | 2007-03 |
|
| Mutagenicity of UV-irradiated maltol in Salmonella typhimurium. | 2007-01 |
|
| Evaluation of certain food additives and contaminants. | 2007 |
|
| Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes. | 2007 |
|
| An in vitro study of interactions between insulin-mimetic zinc(II) complexes and selected plasma components. | 2006-12 |
|
| Prooxidant action of maltol: role of transition metals in the generation of reactive oxygen species and enhanced formation of 8-hydroxy-2'-deoxyguanosine formation in DNA. | 2006-06 |
|
| Metal complexes of maltol and close analogues in medicinal inorganic chemistry. | 2006-06 |
|
| Study on the nitric oxide scavenging effects of ginseng and its compounds. | 2006-04-05 |
|
| Increase in the free radical scavenging activity of ginseng by heat-processing. | 2006-04 |
|
| Maltol inhibits apoptosis of human neuroblastoma cells induced by hydrogen peroxide. | 2006-03-31 |
|
| A new role for old ligands: discerning chelators for zinc metalloproteinases. | 2006-03-15 |
|
| New lipophilic 3-hydroxy-4-pyridinonate iron(III) complexes: synthesis and EXAFS structural characterisation. | 2006-03-14 |
|
| A novel heterocyclic atom exchange reaction with Lawesson's reagent: a one-pot synthesis of dithiomaltol. | 2006-01-14 |
|
| [Studies on the chemical constituents in herb of Ludwigia octovalvis]. | 2005-12 |
|
| Tris(pyronato)- and tris(pyridonato)-ruthenium(III) complexes and solution NMR studies. | 2005-09-19 |
|
| [Studies on chemical constituents in Flos Sophorae Carbonisatus]. | 2005-08 |
|
| Electrochemical determination of maltol in beverages with glassy carbon electrode and its silica sol-gel modified electrode. | 2004-05-28 |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.food-info.net/uk/e/e636.htm
Maltol is used in many products, mainly confectionary and bakery products. The acceptable daily intake is up to 1 mg/kg bodyweight.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25352751
When the retinal ganglion cells were exposed to 20 μM of H2O2 for 16 h, their viability dropped to 40.3±3.4%. However, the maltol treatment restored the cells in a dose-dependent manner. The viability recovered to 73.9±5.1% with 10 μM of maltol and even reached 175.1±11.3% with 2 mM of maltol, as measured by ATP assay.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:48:02 GMT 2025
by
admin
on
Mon Mar 31 17:48:02 GMT 2025
|
| Record UNII |
3A9RD92BS4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-636
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
||
|
JECFA EVALUATION |
INS-636
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
||
|
JECFA EVALUATION |
MALTOL
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID0025523
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
8320
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
SUB34393
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
1375003
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
MALTOL
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
1362894
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | RxNorm | ||
|
3A9RD92BS4
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
3A9RD92BS4
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL31422
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
8369
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
2829
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
100000127991
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
C008316
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
C76894
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
204-271-8
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
404458
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
118-71-8
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
1471
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | |||
|
m7047
Created by
admin on Mon Mar 31 17:48:02 GMT 2025 , Edited by admin on Mon Mar 31 17:48:02 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |